Lipolytic effects of conventional β3-adrenoceptor agonists and of CGP 12,177 in rat and human fat cells: Preliminary pharmacological evidence for a putative β4-adrenoceptor

British Journal of Pharmacology

Volumn 122, Issue 6, 1997, Pages 1244-1250

  Galitzky, Jean ^a   Langin, Dominique ^a   Verwaerde, Patrick ^a   Montastruc, Jean Louis ^a   Lafontan, Max ^a   Berlan, Michel ^a,b  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b INSERM   (France)

Author keywords

Bupranolol; CGP 20712A; CL 316,243; Human adipocytes; Lipolysis; SR 58,611A; SR 59,230A; White adipose tissue

Indexed keywords

1 (2 ETHYLPHENOXY) 3 (1,2,3,4 TETRAHYDRO 1 NAPHTHYLAMINO) 2 PROPANOL OXALATE; 4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; 5 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1,3 BENZODIOXOLE 2,2 DICARBOXYLIC ACID; 5 [2 [[2 HYDROXY 3 [4 (1 METHYL 4 TRIFLUOROMETHYL 2 IMIDAZOLYL)PHENOXY]PROPYL]AMINO]ETHOXY]SALICYLAMIDE; BETA 3 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR; BUPRANOLOL; ISOPRENALINE; SR 56811A; UNCLASSIFIED DRUG;

ADIPOCYTE; ADULT; ANIMAL CELL; ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; LIPOLYSIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030734704     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701523     Document Type: Article

References (53)

1. ARCH, J.R.S. & KAUMANN, A.J. (1993). Beta3-and atypical beta-adrenoceptors. Med. Res. Rev., 13, 663-729.
2. ARNER, P., HELLSTRÖM, L., WAHRENBERG, H. & BRÖNNEGARD, M. (1990). Beta-adrenoceptor expression in human fat cells from different regions. J. Clin. Invest., 86, 1595-1600.
3. ATGIE, C., TAVERNIER, G., D'ALLAIRE, F., BENGTSSON, T., MARTI, L., CARPENE, C., LAFONTAN, M., BUKOWIECKI, L. & LANGIN, D. (1996). β3-Adrenoceptor in guinea pig brown and white adipocytes: low expression and lack of function. Am. J. Physiol., 271, R1729-R1738.
4. ARUNLAKSHANA, O. & SCHILD, H.O. (1959). Some quantitative uses of drug antagonists. Br. J. Pharmacol. Chemother., 14, 48-58.
5. 3-adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue. Br. J. Pharmacol., 117, 907-913.
6. 3-adrenoceptor mRNA in human tissues. Eur. J. Pharmacol., 289, 223-228.
7. BOJANIC, D., JANSEN, J.D., NAHORSKI, S.R. & ZAAGSMA, J. (1985). Atypical characteristics of the β- adrenoceptor mediating cyclic AMP generation and lipolysis in the rat adipocyte. Br. J. Pharmacol., 84, 131-137.
8. BOUSQUET-MELOU, A., GALITZKY, J., CARPENE, C., LAFONTAN, M. & BERLAN, M. (1994). Beta-adrenergic control of lipolysis in primate white fat cells: a comparative study with nonprimate mammals. Am. J. Physiol., 267, R115-R123.
9. BOUSQUET-MELOU, A., GALITZKY, J., LAFONTAN, M. & BERLAN, M. (1995). Control of lipolysis in intra-abdominal fat cells of nonhuman primates: Comparison with humans. J. Lipid Res., 36, 451-461.
10. BRADLEY, D.C. & KASLOW, H.R. (1989). Radiometric assays for glycerol, glucose and glycogen. Anal. Biochem., 180, 11-16.
11. BURNS, T.W., LANGLEY, P.E., TERRY, B.E., BYLUND, D.B., HOFFMAN, B.B., THARP, M.D., LEFKOWITZ, R.J., GARCIA-SAINZ J. A. & FAIN J. N. (1981). Pharmacological characterization of adrenergic receptors in human adipocytes. J. Clin. Invest., 67, 467-475.
12. CHAUDHRY, A., MACKENZIE, R.G., GEORGIC, L.M. & GRANNEMAN, J.G. (1994). Differential interaction of beta(1)-and beta(3)-adrenergic receptors with G(i) in rat adipocytes. Cell. Signal., 6, 457-465.
13. COHEN, M.L., GRANNEMAN, J.G., CHAUDHRY, A., SCHENCK, K.W., CUSHING, D.J. & PALKOWITZ, A. (1995). Is the 'atypical' beta-receptor in the rat stomach fundus the rat beta 3-receptor. J. Pharmacol. Exp. Ther., 272, 446-451.
14. COLLINS, S., DANIEL, K.W., ROHLFS, E.M., RAMKUMAR, V., TAYLOR, I.L. & GETTYS, T.W. (1994). Impaired expression and functional activity of the beta3-and beta 1-adrenergic receptors in adipose tissue of congenitally obese (C57BL/6J ob/ob) mice. Mol. Endocrinol., 8, 518-527.
15. DENG, C.J., PAOLONI-GIACOBINO, A., KUEHNE, F., BOSS, O., REVELLI, J.P., MOINAT, M., CAWTHORNE, M.A., MUZZIN, P. & GIACOBINO, J.P. (1996). Respective degree of expression of beta(1)-, beta(2)-and beta(3)-adrenoceptors in human brown and white adipose tissues. Br. J. Pharmacol., 118, 929-934.
16. EMORINE, L.J., MARULLO, S., BRIEND-SUTREN, M.M., PATEY, G., TATE, K., DELAVIER-KLUTCHKO, C. & STROSBERG, A.D. (1989). Molecular characterization of the human beta3-adrenergic receptor. Science, 245, 1118-1121.
17. GALITZKY, J., REVERTE, M., PORTILLO, M., CARPENE, C., LAFONTAN, M. & BERLAN, M. (1993). Coexistence of beta1-, beta2-and beta3-adrenoceptors in dog fat cells and their differential activation by catecholamines. Am. J. Physiol., 264, E403-E412.
18. GAUTHIER, C., TAVERNIER, G., CHARPENTIER, F., LANGIN, D. & LEMAREC, H. (1996). Functional beta(3)-adrenoceptor in the human heart. J. Clin. Invest., 98, 556-562.
19. HIMMS HAGEN, J., CUI, J., E DANFORTH, J., TAATJES, D.J., LANG, S.S., WATERS, B.L. & CLAUS, T.H. (1994). Effect of CL-316,243, a thermogenic beta3-agonist, on energy balance and brown and white adipose tissue in rats. Am. J. Physiol., 266, R1371-R1382.
20. HOFFSTEDT, J., LONNQVIST, F., SHIMIZU, M., BLAAK, E. & ARNER, P. (1996). Effects of several putative beta(3)-adrenoceptor agonists on lipolysis in human omental adipocytes. Int. J. Obesity., 20, 428-434.
21. HOLLENGA, C., BROUWER, F. & ZAAGSMA, J. (1991). Relationship between lipolysis and cyclic AMP generation mediated by atypical beta-adrenoceptors in rat adipocytes. Br. J. Pharmacol., 102, 577-580.
22. HOLLENGA, C., HAAS, M., DEINUM, J.T. & ZAAGSMA, J. (1990). Discrepancies in lipolytic activities induced by beta-adrenoceptor agonists in human and rat adipocytes. Horm. Metab. Res., 22, 17-21.
23. HOLLENGA, C. & ZAAGSMA, J. (1989). Direct evidence for the atypical nature of functional beta-adrenoceptors in rat adipocytes. Br. J. Pharmacol., 98, 1420-1424.
24. KAUMANN, A.J. (1996). (-)-CGP 12,177-induced increase of human atrial contraction through a putative third beta-adrenoceptor. Br. J. Pharmacol., 117, 93-98.
25. KAUMANN, A.J. & MOLENAAR, P. (1996). Differences between the third cardiac beta-adrenoceptor and the colonic beta(3)-adrenoceptor in the rat. Br. J. Pharmacol., 118, 2085-2098.
26. KRIEF, S., LÖNNQVIST, F., RAIMBAULT, S., BAUDE, B., VAN PRONSEN, A., ARNER, P., STROSBERG, A.D., RICQUIER, D. & EMORINE, L.J. (1993) Tissue distribution of beta 3-adrenergic receptor mRNA in man. J. Clin. Invest., 91, 344-349.
27. KOIKE, K., TAKAYANAGI, I. & YAMAZAKI, M. (1996). Differentiation of binding sites of CGP 12177, a beta 3-adrenoceptor partial agonist, and carteolol, a beta 1/beta 2-adrenoceptor partial agonist, to the beta-adrenoceptors in guinea-pig taenia caecum. Can. J. Physiol. Pharmacol., 74, 928-933.
28. LAFONTAN, M. & BERLAN, M. (1993). Fat cell adrenergic receptors and the control of white and brown fat cell function. J. Lipid Res., 34, 1057-1091.
29. LANDS, A.M., ARNOLD, A.M., MCULIFF, J.P. & LUDUENA, F.P. (1967). Differentiation of receptor systems activated by sympathomimetic amines. Nature, 214, 597-598.
30. LANGIN, D., EKHOLM, D., RIDDERSTRALE, M., LAFONTAN, M. & BELFRAGE, P. (1992). cAMP-dependent protein kinase activation mediated by β3-adrenergic receptors parallels lipolysis in rat adipocytes. Biochim. Biophys. Acta, 1135, 349-352.
31. LANGIN, D., PORTILLO, M., SAULNIER-BLACHE, J.-S. & LAFONTAN, M. (1991). Coexistence of three beta-adrenergic receptor subtypes in white fat cells of various mammalian species. Eur. J. Pharmacol., 199, 291-301.
32. LEVASSEUR, S., PIGEON, C., REYL-DESMARS, F., CAPUT, D & LEWIN, M.J.M. (1995). Adenylyl cyclase stimulation by the human and rat β3 adrenergic receptor isoforms expressed in the CHO cell. Gastroenterol. Clin. Biol., 19, 668-672.
33. LEVASSEUR, S., BADO, A., LAIGNEAU, J.-P., MOIZO, L., REYLDESMARS, F. & LEWIN, M.J.M. (1997). Characterization of a β3-adrenoceptor stimulating gastrin and somatostatin secretions in rat antrum. Am. J. Physiol., 272, G1000-G1006.
34. LÖNNQVIST, F., KRIEF, S., STROSBERG, A.D., NYBERG, B., EMORINE, L.J. & ARNER, P. (1993). Evidence for a functional β3-adrenoceptor in man. Br. J. Pharmacol., 110, 929-936.
35. LÖNNQVIST, F., THORNE, A., NILSELL, K., HOFFSTEDT, J. & ARNER, P. (1995). A pathogenic role of visceral fat beta(3)-adrenoceptors in obesity. J. Clin. Invest., 95, 1109-1116.
36. MALINOWSKA, B. & SCHLICKER, E. (1996). Mediation of the positive chronotropic effect of CGP 12,177 and cyanopindolol in the pithed rat by atypical β-adrenoceptors, different from β3-adrenoceptors. Br. J. Pharmacol., 117, 943-949.
37. MANARA, L., BADONE, D., BARONI, M., BOCCARDI, G., CECCHI, R., CROCI, T., GIUDICE, A., GUZZI, U., LANDI, M. & LE FUR, G. (1996). Functional identification of rat atypical beta-adrenoceptors by the first beta(3)-selective antagonists, aryloxypropanolaminotetralins. Br. J. Pharmacol., 117, 435-442.
38. MANARA, L., CROCI, T. & LANDI, M. (1995). beta(3)-adrenoceptors and intestinal motility. Fundam. Clin. Pharmacol., 9, 332-342.
39. MAURIÈGE, P., DE PERGOLA, G., BERLAN, M. & LAFONTAN, M. (1988). Human fat cell beta-adrenergic receptors : beta agonist-dependent lipolytic responses and characterization of beta-adrenergic binding sites on human fat cell membranes with highly selective beta1-antagonists. J. Lipid Res., 29, 587-601.
40. MCLAUGHLIN, D.P. & DONALD, A.M. (1991). Characterization of catecholamine-mediated relaxations in rat isolated gastric fundus: evidence for an atypical beta-adrenoceptor. Br. J. Pharmacol., 103, 1351-1356.
41. NAHMIAS, C., BLIN, N., ELALOUF, J.-M., MATTEI, M.G., STROSBERG, A.D. & EMORINE, L.J. (1991). Molecular characterization of the mouse beta3-adrenergic receptor: relationship with the atypical receptor of adipocytes. EMBO J., 10, 3721-3727.
42. NISOLI, E., TONELLO, C., LANDI, M. & CARRUBA, M.O. (1996). Functional studies of the first selective beta 3-adrenergic receptor antagonist SR 59230A in rat brown adipocytes. Mol. Pharmacol., 49, 7-14.
43. NORMAN, B.J. & LEATHARD, H.L. (1990). Evidence that an atypical beta-adrenoceptor mediates the inhibition of spontaneous rythmical contractions of rabbit isolated jejunum induced by ritodrine and salbutamol. Br. J. Pharmacol., 101, 27-30.
44. ORIOWO, M.A. (1995). Different atypical beta-adrenoceptors mediate isoprenaline-induced relaxation in vascular and non-vascular smooth muscles. Life Sci., 56, 269-275.
45. PIETRI-ROUXEL, F., LENZEN, G., KAPOOR, A., DRUMARE, M.F., ARCHIMBAULT, P., STROSBERG, A.D. & MANNING, B.S.J. (1995). Molecular cloning and pharmacological characterization of the bovine beta 3-adrenergic receptor. Eur. J. Biochem., 230, 350-358.
46. REVELLI, J.P., MUZZIN, P., PAOLINI, A., MOINAT, M. & GIACOBINO, J-P. (1993). Expression of the β3-adrenergic receptor in human white adipose tissue. J. Mol. Endocrinol., 10, 193-197.
47. SHEN, Y.T., CERVONI, P., CLAUS, T. & VATNER, S.F. (1996). Differences in beta(3)-adrenergic receptor cardiovascular regulation in conscious primates, rats and dogs. J. Pharmacol. Exp. Ther., 278, 1435-1443.
48. STROSBERG, A.D. & PIETRI-ROUXEL, F. (1996). Function and regulation of the beta(3)-adrenoceptor. Trends Pharmacol. Sci., 17, 373-381.
49. TAVERNIER, G., BARBE, P., GALITZKY, J., BERLAN, M., CAPUT, D., LAFONTAN, M. & LANGIN, D. (1996). Expression of β3-adrenoceptors with low lipolytic action in human subcutaneous white adipocytes. J. Lipid. Res., 37, 87-97.
50. UMEKAWA, T., YOSHIDA, T., SAKANE, N. & KONDO, M. (1996). Effect of CL316,243, a highly specific beta(3)-adrenoceptor agonist, on lipolysis of human and rat adipocytes. Horm. Metab. Res., 28, 394-396.
51. VAN LIEFDE, I., WITZENBURG, A.V. & VAUQUELIN, G. (1992). Multiple beta-adrenergic receptor subclasses mediate the 1-isoproterenol-induced lipolytic responses in rat adipocytes. J. Pharmacol. Exp. Ther., 262, 552-558.
52. WILSON, C., WILSON, S., PIERCY, V., SENITT, M.V. & ARCH, J.R.S. (1984). The rat lipolytic β-adrenoceptor: studies using novel - adrenoceptor agonists. Eur. J. Pharmacol., 100, 309-316.
53. WILSON, S., CHAMBERS, J.K., PARK, J.E., LADURNER, A., CRONK, D.W., CHAPMAN, C.G., KALLENDER, H., BROWNE, M.J., MURPHY G.J. & YOUNG, P.W. (1996) Agonists potency at the cloned human β3-adrenoceptor depends on receptor expression level and nature of assay. J. Pharmacol. Exp. Ther., 279, 214-221.